Studies conducted to date suggest that CGRP receptor antagonism might be a safer approach than triptan administration in migraine treatment, with no cardiovascular adverse effects reported.

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

This blockage of CGRP signals is crucial and exactly why butterbur is effective in the prevention of migraine attacks ... showing promising benefits when taken during allergy season, according ...

Atogepant, a new oral prescription drug, shows promise in preventing migraines by targeting CGRP receptors, reducing migraine ...

Meanwhile, two oral CGRP inhibitors – AbbVie’s Ubrelvy and BioHaven’s Nurtec – have been launched for the on-demand treatment of acute migraine attacks. These don’t compete with Aimovig ...

As the last of the anti-CGRP mAbs to enter the migraine market ... as well as highlighting meaningful benefits of Vyepti treatment. Post hoc analysis of the long-term, open-label Phase III ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in ...

“As we work to bring the benefits of AJOVY to younger ... As an anti-CGRP treatment, it targets the underlying causes of migraines and has demonstrated consistent efficacy in reducing the ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention ... work to bring the benefits of AJOVY to ...